Skip to main content
. 2017 Jan 9;83(5):976–990. doi: 10.1111/bcp.13183

Table 3.

Pharmacokinetic parameters for administered compounds

Fentanyl (S)‐ketamine Norketamine Phenytoin Ibuprofen Imipramine Desipramine Pregabalin
C max (ng ml –1 ) 1.23 ± 0.66 52.4 ± 15.7 23.2 ± 5.7 8280 ± 1740 53 300 ± 9360 77.2 ± 21.1 25.4 ± 14.6 9650 ± 1880
T max (h) 0.50 (0.50–1.22) 0.50 (0.50–2.33) 1.10 (1.05–3.05) 0.55 (0.50–2.13) 2.02 (1.08–3.00) 3.12 (1.08–6.00) 6.00 (2.07–10.00) 1.56 (1.08–5.00)
T 1/2 (h) 2.52 ± 1.08 3.12 ± 1.30 4.89 ± 1.14 12.50 ± 2.86 1.80 ± 0.29 6.54 ± 1.96 56.2 ± 8.7 5.30 ± 0.58
AUC 0–last (ng hr ml –1 ) 2.21 ± 0.72 102 ± 18.6 129 ± 35.7 54 500 ± 7980 174 000 ± 30 200 441 ± 128 163 ± 99.2 49 700 ± 7340
AUC 0–inf (ng hr ml –1 ) 3.10 ± 0.84 111 ± 22.2 180 ± 54.6 135 000 ± 34 800 182 000 ± 35 600 782 ± 193 517 ± 100 71 200 ± 9860
Clearance (l hr –1 ) 1.05 ± 0.32 93.6 ± 20.1 60.2 ± 17.7 2.36 ± 0.54 NC NC NC NC
V d (l) 3.56 ± 1.29 410 ± 153 411 ± 106 40.60 ± 4.97 NC NC NC NC

Data are means ± standard deviation and median (range) for Tmax.

AUC0–inf, estimated area under the plasma concentration‐time curve from time of dosing to infinity; AUC0–last, area under the plasma concentration‐time curve from time of dosing to the last observation; Cmax, maximum concentration; Tmax, time at which Cmax was observed; T1/2, apparent terminal half‐life; Vd, apparent volume of distribution of the drug; NC, not calculated.